Mori H, Hashiramoto M, Kishimoto M, Kasuga M
Second Department of Internal Medicine, Kobe University School of Medicine, Japan.
J Clin Endocrinol Metab. 1995 Sep;80(9):2822-6. doi: 10.1210/jcem.80.9.7673430.
By using polymerase chain reaction-restriction length polymorphism and polymerase chain reaction-single-strand conformation polymorphism analysis, we screened 283 Japanese subjects [226 noninsulin-dependent diabetes mellitus (NIDDM), 12 impaired glucose tolerance, and 45 normal controls] for 2 amino acid polymorphisms, Ala513Pro and Gly972Arg, of the insulin receptor substrate-1. Only 8 NIDDM, 1 impaired glucose tolerance, and 1 normal subject were identified to be heterozygous for the Gly972Arg mutation, whereas no subject had an Ala513Pro polymorphism. The frequency of Gly972Arg was lower than recently reported in Danish and Finnish populations and was in good agreement with that previously reported in another Japanese cohort. Analysis of 1 pedigree of 1 NIDDM patient with a Gly972Arg showed no co-segregation between this polymorphism and the onset of NIDDM. Our results suggest that the Gly972Arg polymorphism does not play an important role in the pathogenesis of NIDDM in Japanese patients.
通过聚合酶链反应-限制性片段长度多态性分析和聚合酶链反应-单链构象多态性分析,我们对283名日本受试者[226例非胰岛素依赖型糖尿病(NIDDM)、12例糖耐量受损和45例正常对照]进行了胰岛素受体底物-1的2个氨基酸多态性Ala513Pro和Gly972Arg的筛查。仅8例NIDDM、1例糖耐量受损和1例正常受试者被鉴定为Gly972Arg突变的杂合子,而没有受试者具有Ala513Pro多态性。Gly972Arg的频率低于最近在丹麦和芬兰人群中报道的频率,并且与先前在另一日本队列中报道的频率高度一致。对1例携带Gly972Arg的NIDDM患者的1个家系进行分析,结果显示该多态性与NIDDM的发病之间没有共分离现象。我们的结果表明,Gly972Arg多态性在日本患者NIDDM的发病机制中不发挥重要作用。